The cost-effectiveness of Celecoxib and Rofecoxib in patients with osteoarthritis or rheumatoid arthritis
By: Canadian Coordinating Office for Health Technology Assessment
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Number of pages: 39
Subjects: Arthritis, rheumatoid -- drug therapy; Osteoarthritis -- drug therapy
Notes: "February 2002" Technology Report

2